Search Results - "Popat, Uday R."

Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia by Kadia, Tapan M, Reville, Patrick K, Wang, Xuemei, Rausch, Caitlin R, Borthakur, Gautam, Pemmaraju, Naveen, Daver, Naval G, DiNardo, Courtney D, Sasaki, Koji, Issa, Ghayas C, Ohanian, Maro, Montalban-Bravo, Guillermo, Short, Nicholas J, Jain, Nitin, Ferrajoli, Alessandra, Bhalla, Kapil N, Jabbour, Elias, Takahashi, Koichi, Malla, Rashmi, Quagliato, Kelly, Kanagal-Shamanna, Rashmi, Popat, Uday R, Andreeff, Michael, Garcia-Manero, Guillermo, Konopleva, Marina Y, Ravandi, Farhad, Kantarjian, Hagop M

“…The combination of venetoclax and 5-azacitidine (5-AZA) for older or unfit patients with acute myeloid leukemia (AML) improves remission rates and survival…”
Get full text

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL by Saini, Neeraj, Marin, David, Ledesma, Celina, Delgado, Ruby, Rondon, Gabriela, Popat, Uday R., Bashir, Qaiser, Hosing, Chitra M., Nieto, Yago, Alousi, Amin M., Qazilbash, Muzaffar H., Ciurea, Stefan, Shpall, Elizabeth, Khouri, Issa, Kantarjian, Hagop, Jabbour, Elias, Ravandi, Farhad, Champlin, Richard E., Kebriaei, Partow

“…How to best use tyrosine kinase inhibitors (TKIs) of BCR-ABL after allogeneic stem cell transplantation for Philadelphia chromosome–positive acute…”
Get full text

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation by Shah, Mithun Vinod, Saliba, Rima M., Rondon, Gabriela, Chen, Julianne, Soebbing, Doris, Rus, Ioana, Alousi, Amin, Oran, Betul, Kebriaei, Partow, Qazilbash, Muzaffar, Parmar, Simrit, Hosing, Chitra, Khouri, Issa F., Popat, Uday R., Champlin, Richard E., Ciurea, Stefan O.

“…Allogeneic SCT for older patients remains challenging at least in part due to graft-versus-host disease (GVHD) and higher non-relapse mortality (NRM). We…”
Get full text

Significance of minimal residual disease monitoring by real‐time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes by Yalniz, Fevzi F., Patel, Keyur P., Bashir, Qaiser, Marin, David, Ahmed, Sairah, Alousi, Amin M., Chen, Julianne, Ciurea, Stefan O., Rezvani, Katy, Popat, Uday R., Shpall, Elizabeth J., Champlin, Richard E., Oran, Betül

“…Background Despite the well‐defined role of minimal residual disease (MRD) monitoring by real‐time quantitative polymerase chain reaction (RT‐PCR) for…”
Get full text

Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD by Mehta, Rohtesh S., Bassett, Roland, Rondon, Gabriela, Overman, Bethany J., Popat, Uday R., Hosing, Chitra M., Rezvani, Katy, Qazilbash, Muzaffar H., Anderlini, Paolo, Jones, Roy B., Kebriaei, Partow, Marin, David, Khouri, Issa F., Oran, Betul, Ciurea, Stefan O., Kondo, Kayo, Couriel, Daniel R., Shpall, Elizabeth J., Champlin, Richard E., Alousi, Amin M.

“…Steroids remain the initial therapy for acute graft-vs.-host disease (AGVHD). Strategies to improve response and minimize steroid exposure are needed. We…”
Get full text

A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study by Popat, Uday R, Andersson, Borje S, Bassett, Roland, Kawedia, Jitesh, Valdez, Ben C, Alousi, Amin M, Al-Atrash, Gheath, Bashir, Qaiser, Hosing, Chitra M, Im, Jin S, Kebriaei, Partow, Marin, David, Nieto, Yago, Oran, Betul, Olson, Amanda, Qazilbash, Muzaffar H, Srour, Samer A, Shpall, Elizabeth J, Champlin, Richard E, Mehta, Rohtesh S

Get full text

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial by Mehta, Rohtesh S, Bassett, Roland, Olson, Amanda, Chen, Julianne, Ahmed, Sairah, Alousi, Amin M, Anderlini, Paolo, Al-Atrash, Gheath, Bashir, Qaiser, Ciurea, Stefan O, Hosing, Chitra M, Im, Jin S, Kebriaei, Partow, Khouri, Issa, Marin, David, Molldrem, Jeffrey J, Nieto, Yago, Oran, Betul, Rezvani, Katayoun, Qazilbash, Muzaffar H, Srour, Samer A, Shpall, Elizabeth J, Andersson, Borje S, Champlin, Richard E, Popat, Uday R

Get full text

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia by Olson, Amanda L, Saliba, Rima M, Oran, Betul, Chen, Julianne, Alousi, Amin, Ahmed, Sairah, Bashir, Qaiser, Ciurea, Stefan O, Hosing, Chitra, Seon Im, Jin, Kebriaei, Partow, Khouri, Issa F, Mehta, Rohtesh, Nieto, Yago, Parmar, Simrit, Rezvani, Katy, Shah, Nina, Shpall, Elizabeth, Srour, Samer A, Qazilbash, Muzaffar, Andersson, Borje S, Champlin, Richard, Popat, Uday R

“…Acute myeloid leukemia (AML) patients not in remission and beyond first or second complete remission are considered allogeneic stem cell transplant (SCT)…”
Get more information

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation by Saberian, Chantal, Abdel-Wahab, Noha, Abudayyeh, Ala, Rafei, Hind, Joseph, Jacinth, Rondon, Gabriela, Whited, Laura, Gruschkus, Stephen, Fa'ak, Faisal, Daher, May, Knape, Cristina, Safa, Houssein, Shoukier, Mahran, Suarez-Almazor, Maria E, Marcotulli, Megan, Ludford, Kaysia, Gulbis, Alison M, Konopleva, Marina, Ohanian, Maro, Ravandi, Farhad, Garcia-Manero, Guillermo, Oran, Betul, Popat, Uday R, Mehta, Rotesh, Alousi, Amin M, Daver, Naval, Champlin, Richard, Diab, Adi, Al-Atrash, Gheath

“…BackgroundImmune checkpoint inhibitors (ICIs) are being used after allogeneic hematopoietic stem cell transplantation (alloHCT) to reverse immune dysfunction…”
Get full text

Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients by Sheshadri, Ajay, Alousi, Amin, Bashoura, Lara, Stolar, Karen, Baghaie, Shiva, Arain, Muhammad H, Noor, Laila, Balagani, Amulya, Jain, Akash, Blanco, David, Ortiz, Abel, Peterson, Susan K, Langhals, Renee, Taylor, Michael, Stenzler, Alex, Mehta, Rohtesh S, Popat, Uday R, Hosing, Chitra, Rondon, Gabriela, Shen, Fan, Li, Liang, Cheng, Guang-Shing, Ost, David E, Champlin, Richard E, Dickey, Burton F

Get full text

Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability by Sheshadri, Ajay, Makhnoon, Sukh, Alousi, Amin M, Bashoura, Lara, Andrade, Rene, Miller, Christopher J, Stolar, Karen R, Arain, Muhammad Hasan, Noor, Laila, Balagani, Amulya, Jain, Akash, Blanco, David, Ortiz, Abel, Taylor, Michael S, Stenzler, Alex, Mehta, Rohtesh, Popat, Uday R, Hosing, Chitra, Ost, David E, Champlin, Richard E, Dickey, Burton F, Peterson, Susan K

“…Home-based spirometry (HS) allows for the early detection of lung complications in recipients of an allogeneic hematopoietic cell transplant (AHCT). Although…”
Get full text

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial by Marin, David, Li, Ye, Basar, Rafet, Rafei, Hind, Daher, May, Dou, Jinzhuang, Mohanty, Vakul, Dede, Merve, Nieto, Yago, Uprety, Nadima, Acharya, Sunil, Liu, Enli, Wilson, Jeffrey, Banerjee, Pinaki, Macapinlac, Homer A., Ganesh, Christina, Thall, Peter F., Bassett, Roland, Ammari, Mariam, Rao, Sheetal, Cao, Kai, Shanley, Mayra, Kaplan, Mecit, Hosing, Chitra, Kebriaei, Partow, Nastoupil, Loretta J., Flowers, Christopher R., Moseley, Sadie Mae, Lin, Paul, Ang, Sonny, Popat, Uday R., Qazilbash, Muzaffar H., Champlin, Richard E., Chen, Ken, Shpall, Elizabeth J., Rezvani, Katayoun

“…There is a pressing need for allogeneic chimeric antigen receptor (CAR)-immune cell therapies that are safe, effective and affordable. We conducted a phase 1/2…”
Get full text

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity by Varma, Ankur, Abraham, Susan C., Mehta, Rohtesh S., Saini, Neeraj Y., Honhar, Medhavi, Rashid, Munazza, Chen, Julianne, Srour, Samer A., Bashir, Qaiser, Rondon, Gabriela, Oran, Betul, Hosing, Chitra M., Nieto, Yago, Kebriaei, Partow, Alousi, Amin M., Ahmed, Sairah, Marin, David, Khouri, Issa F., Ciurea, Stefan O., Qazilbash, Muzaffar H., Rezvani, Katy, Anderlini, Paolo, Andersson, Borje S., Shpall, Elizabeth J., Champlin, Richard E., Popat, Uday R.

“…At our center, we observed a series of patients who developed transudative refractory ascites secondary to noncirrhotic, non-veno-occlusive disease…”
Get full text

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia by Shah, Mithun Vinod, Jorgensen, Jeffrey L., Saliba, Rima M., Wang, Sa A., Alousi, Amin M., Andersson, Borje S., Bashir, Qaiser, Ciurea, Stefan O., Kebriaei, Partow, Marin, David, Patel, Keyur P., Popat, Uday R., Rezvani, Katy, Rondon, Gabriela, Shpall, Elizabeth J., Champlin, Richard E., Oran, Betül

“…•In acute myeloid leukemia patients undergoing allogeneic transplant, minimal residual disease–based risk stratification identifies patients at a high risk of…”
Get full text

Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy by Venugopal, Sangeetha, Shoukier, Mahran, Konopleva, Marina, Dinardo, Courtney D., Ravandi, Farhad, Short, Nicholas J., Andreeff, Michael, Borthakur, Gautam, Daver, Naval, Pemmaraju, Naveen, Sasaki, Koji, Montalban‐Bravo, Guillermo, Marx, Kayleigh R., Pierce, Sherry, Popat, Uday R., Shpall, Elizabeth J., Kanagal‐Shamanna, Rashmi, Garcia‐Manero, Guillermo, Kantarjian, Hagop M., Kadia, Tapan M.

“…Background Venetoclax (VEN) in combination with a hypomethylating agent (HMA) has become the standard of care for patients aged >75 years and for those not…”
Get full text

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies by Ramos, Carlos A, Saliba, Rima M, de Padua, Leandro, Khorshid, Ola, Shpall, Elizabeth J, Giralt, Sergio, Patah, Poliana A, Hosing, Chitra M, Popat, Uday R, Rondon, Gabriela, Khouri, Issa F, Nieto, Yago L, Champlin, Richard E, de Lima, Marcos

“…1 Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA 2 Departamento de…”
Get full text

Better allele-level matching improves transplant-related mortality after double cord blood transplantation by Oran, Betül, Cao, Kai, Saliba, Rima M, Rezvani, Katayoun, de Lima, Marcos, Ahmed, Sairah, Hosing, Chitra M, Popat, Uday R, Carmazzi, Yudith, Kebriaei, Partow, Nieto, Yago, Rondon, Gabriela, Willis, Dana, Shah, Nina, Parmar, Simrit, Olson, Amanda, Moore, Brandt, Marin, David, Mehta, Rohtesh, Fernández-Viña, Marcelo, Champlin, Richard E, Shpall, Elizabeth J

“…Cord blood transplant requires less stringent human leukocyte antigen matching than unrelated donors. In 133 patients with hematologic malignancies who…”
Get full text

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents by Kyvernitakis, Andreas, Mahale, Parag, Popat, Uday R, Jiang, Ying, Hosry, Jeff, Champlin, Richard E, Torres, Harrys A

“…Abstract There is paucity of literature regarding hepatitis C virus (HCV) infection in hematopoietic cell transplant (HCT) recipients. In the study described…”
Get full text

Role of Outpatient Physical Medicine and Rehabilitation in a Multidisciplinary Prehabilitation Program for Older Adults Before Allogeneic Hematopoietic Stem Cell Transplant by Cheng, Jessica T, Obaisi, Obada, Yadav, Rajesh, Gupta, Ekta, Fu, Jack B, Bruera, Eduardo, Collaco, Alisha, Szewczyk, Nicholas, Popat, Uday R, Ngo-Huang, An

“…Physical rehabilitation is increasingly incorporated throughout the allogeneic hematopoietic stem cell transplant journey for older adults. This study aimed to…”
Get full text

Unravelling ALL: The Keys to Improved Post-Transplant Survival in Acute Lymphoblastic Leukemia by Pasvolsky, Oren, Popat, Uday R.

Get full text